Rankings
▼
Calendar
TARA Q2 2018 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TARA
Protara Therapeutics, Inc.
$211M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-11.09
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$922,000
Balance Sheet
Total Assets
$28M
Total Liabilities
$2M
Stockholders' Equity
$26M
Cash & Equivalents
$12M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$5M
-$6M
+16.5%
Net Income
-$5M
-$6M
+13.0%
← FY 2018
All Quarters
Q3 2018 →